Atherosclerosis and Lipoproteins |
From the Department of Genetics, Southwest Foundation for Biomedical Research, San Antonio, Tex.
Correspondence to David L. Rainwater, PhD, Department of Genetics, Southwest Foundation for Biomedical Research, PO Box 760549, San Antonio, TX 78245-0549. E-mail david{at}darwin.sfbr.org
| Abstract |
|---|
|
|
|---|
P=0.018). However,
LDLCRC and Lp(a)RC were strongly correlated
(
P=0.382), and partitioning the correlations revealed
significant genetic and environmental correlations
(
G=0.587 and
E=0.251, respectively). The
results suggest that increasing both dietary fat and dietary
cholesterol caused significant increases in Lp(a)
concentrations and that the response to dietary cholesterol
was mediated by a gene or suite of genes that appears to exert
pleiotropic effects on LDLC levels as well. The gene(s) influencing
Lp(a) response to dietary cholesterol is not linked to the
LPA locus.
Key Words: Lp(a) apo(a) baboons genetics
| Introduction |
|---|
|
|
|---|
A number of studies have reported significant, albeit modest, effects on Lp(a) concentrations by various environmental factors. One such intensely studied factor has been diet. The type of dietary fat, for example, can exert significant effects on Lp(a), with trans fatty acids tending to increase levels and saturated fats tending to decrease levels.6 7 However, many studies investigating changes in the level of fat and/or cholesterol in the diet have found no appreciable effects on Lp(a) in humans and nonhuman primates.8 9 10 11 12 In contrast, we have reported significant increases of Lp(a) concentrations in baboons when levels of fat and/or cholesterol were increased in the diet.13 14 Preliminary analyses of data from 139 baboons indicated that sire group membership had a significant effect, suggesting that genes mediated the Lp(a) response to dietary fat and cholesterol.14
To address the question of genetic mediation of dietary response, we have expanded the earlier study to include data for 633 pedigreed baboons in 10 sire families to characterize the Lp(a) diet response.
| Methods |
|---|
|
|
|---|
Diet Protocol
The diet protocol has been described elsewhere.15
In brief, the baboons were fed a basal diet, low in fat (4% of
calories) and cholesterol (0.03 mg/kcal), for at least 7
weeks before collection of the basal diet blood sample. They were then
fed a diet enriched in fat (40% of calories from lard) and
cholesterol (1.7 mg/kcal; HFHC diet) for 7 weeks before
collection of the HFHC diet blood sample. After a 7-week washout period
on the basal diet, the baboons were then fed a diet enriched in fat
only (40% of calories from lard, 0.03 mg cholesterol/kcal;
HFLC diet) for 7 weeks before collection of the HFLC diet blood sample.
For each blood sample, baboons were fasted overnight and
immobilized with ketamine, and blood was drawn from
the femoral vein. At the time of the first sample (basal diet), the
weight (kg) of each animal was recorded. Serum was prepared by
low-speed centrifugation and stored at -80°C in
single-use aliquots as described,16 protected from
oxidation and desiccation.
Measurement of Lp(a) and LDL Cholesterol Concentrations
Serum Lp(a) concentrations were measured using a commercial kit
[Apo-Tek Lp(a), Sigma Diagnostics], which is specific for
Lp(a) particles by virtue of requiring sequential binding by antibodies
directed against both apo(a) and apoB.17 Samples were
assayed as suggested by the supplier, and all 3 diet samples from each
baboon were run together on the same plate. Control products
supplied with the kit gave coefficient of variation estimates of 8.3%
at 7.7 mg/dL (n=50) and 6.4% at 25.7 mg/dL (n=36). Assay repeatability
for baboon samples was 98.0% based on 50 replicated samples. To
further verify reliability of the assay for baboon Lp(a), we compared
Lp(a) values for the same samples14 that had been measured
with our baboon-specific assay.17 We found a high degree
of correlation for the 2 assays
(r2=0.91, n=410; data not shown).
Cholesterol concentrations were measured enzymatically18 19 with reagents supplied by Boehringer Mannheim Diagnostics and a Ciba-Corning Express Plus clinical chemistry analyzer. Cholesterol in HDL was determined in the supernatant after precipitation of apoB-containing lipoproteins with heparin-Mn2+.20 Average coefficients of variation for control products in these assays were 2.2% and 4.6% for total and HDL cholesterol, respectively. Cholesterol concentration in ß-lipoproteins was calculated as the difference between total serum and HDL cholesterol, and this value reflects contributions primarily from LDLs, with relatively minor contributions from VLDL and IDL and variable contributions from Lp(a). Although it is possible that there is some variation in lipid amount per Lp(a) particle for different diets, the Lp(a) cholesterol concentration was estimated as 30% of Lp(a) mass.21 This value was subtracted from ß-lipoprotein cholesterol to estimate the non-Lp(a)/non-HDL cholesterol concentration (termed LDLC in this report) in each sample.
Three concentration variables were calculated from assays of the 3 diet samples from each baboon: Lp(a)Basal (the basal diet values) and 2 variables representing response to dietary fat [Lp(a)RF, calculated as Lp(a)HFLC-Lp(a)Basal] and response to dietary cholesterol [Lp(a)RC, calculated as Lp(a)HFHC-Lp(a)HFLC]. These same 3 variables were also calculated for LDLC.
Determination of LPA Genotypes
LPA genotypes were inferred on the basis of
the apo(a) size polymorphism. Serum samples were treated with SDS
under reducing conditions, and apo(a) isoform phenotypes
were resolved by electrophoresis in acrylamide gradient
gels and detected using a previously described system that identifies
12 isoform sizes in baboons.13 Transmission of
parental isoforms to offspring was verified by running samples from
family members in adjacent lanes. Thus, isoform phenotypes
marked, within families, alleles that were identical by descent.
Single-banded samples can result from 1 of 2 conditions: homozygous for
size or heterozygous-null. The family analyses allowed us to
differentiate most (
86%) of the single-band cases; the
genotype field was blanked for the animals we could not
differentiate before linkage analyses were performed.
Statistical Genetic Analyses
We used univariate quantitative genetic
analyses22 to assess heritability and covariate
effects on serum Lp(a) concentrations and Lp(a) response variables.
Covariate effects (including sex, sex-specific age, and weight terms)
were simultaneously estimated with the heritabilities. We
used bivariate quantitative genetic analyses on LDLC and Lp(a)
data to simultaneously calculate the means, SDs, residual
heritabilities, and covariate effects for each trait, as well as
genetic (
G) and environmental
(
E) correlations between
traits.23 Nonzero genetic correlations between traits
imply that the same gene or genes influence both traits. Total
phenotypic correlations (
P) were calculated as
P=
h12
·
h22 ·
G+
(1-h12)
·
(1-h22) ·
E, where
h12 and
h22 represent
heritabilities for traits 1 and 2, respectively. Probability values
were estimated, using likelihood-ratio tests, by comparing the
likelihood of a model allowing for the parameter with the
likelihood of a model in which the parameter was fixed at
zero.
To test whether the LPA locus was linked to quantitative
trait loci (QTLs) for the different Lp(a) phenotypes, we used
variance component methodologies as implemented in the computer program
SOLAR.24 25 Variance component
methodologies are a strategy to estimate the proportion of the total
phenotypic variance that is attributable to the region around a
specific genetic locus, ie, a test for linkage.26 In
SOLAR, the expected genetic covariance between
relatives is modeled as a function of the identity-by-descent
relationships at the marker locus. By using maximum likelihood methods,
the total phenotypic variance can be partitioned into components due to
covariate effects, LPA locus effects, and residual additive
genetic effects (heritability). The likelihood-ratio statistic, which
is asymptotically distributed as a
2, was used
to test whether the variance attributable to allele sharing among
relatives at the LPA locus was significantly greater than
zero.
| Results |
|---|
|
|
|---|
|
Genetic Effects on Lp(a) and Lp(a) Response to Dietary
Cholesterol
We used univariate genetic analyses to
determine whether genes influence Lp(a) concentrations and their
responses to dietary fat and cholesterol. Table 1
gives trait means, covariate effects,
and heritabilities (h2) for serum
Lp(a) concentrations in the basal diet sample
[Lp(a)Basal] and the cholesterol
response variable Lp(a)RC. As expected,
heritability for serum Lp(a) concentrations on the basal diet was very
high (h2=0.881) and was even higher
for the other diets
(h2HFLC=0.948 and
h2HFHC=0.938, data
not shown). The heritability of Lp(a)RC also was
significant (P<0.0001), but moderate
(h2=0.347). However, there was no
evidence for genetic effects on Lp(a)RF
(h2=0.043±0.049, P=0.28;
data not shown).
|
Tests for Linkage of Lp(a) Concentrations to
LPA
Because LPA, the locus encoding the apo(a) protein, is
known to have a strong effect on Lp(a) concentrations, we conducted
variance component linkage analyses (after assuming that
recombination,
, was zero) between LPA and QTLs for the
heritable traits Lp(a)Basal and
Lp(a)RC. LPA genotypes,
inferred from serum apo(a) phenotypes, were available for 601
pedigreed baboons. Table 2
gives the
results of the linkage analyses. As expected for the basal
diet, all the genetic variance in Lp(a) levels was linked to the
LPA locus with a log10 of the odds in
favor of linkage (LOD) score of 30.5. However, allele sharing at
the LPA locus among relatives did not account for a
significant proportion of the variance in cholesterol
response (LOD score was 0.036, P>0.05). Therefore, there
was no evidence for linkage of a QTL for Lp(a) response to dietary
cholesterol to the LPA locus.
|
Lp(a) Variation Is Genetically Correlated With LDLC
Variation
Because it is a variant LDL particle, a reasonable mechanism for
the non-LPArelated variation in Lp(a) concentrations would
be general metabolic effects on ß-lipoproteins. To test
this hypothesis, we calculated the concentrations of non-HDL
cholesterol not associated with Lp(a) (ie, LDLC) and tested
for correlation with Lp(a) concentrations. Table 3
presents the results of bivariate
genetic analyses for 2 pairs of traits, Lp(a) and LDL
concentrations for basal diet and for cholesterol response.
Bivariate analyses of fat response are not included in the
table because this trait had very low heritabilities for both Lp(a) and
LDLC. For the basal diet traits, the overall phenotypic correlation was
low (
P=0.108), but significant
(P=0.013) when compared with a model in which neither
genetic nor environmental correlation was estimated. Subsequent
analyses indicated that most of this correlation was
attributable to the environmental component (ie,
E=0.332± 0.120 when
G was fixed at zero). In contrast, for the
dietary cholesterol response variables, the phenotypic
correlation was moderate (
P=0.382) and, when
partitioned, both the genetic and environmental correlations were
significant. In fact, about one third of the shared variation in the 2
traits was influenced by a common suite of genes (ie,
G2=0.34).
|
| Discussion |
|---|
|
|
|---|
It is important to recognize 2 methodological limitations that could
affect our results. First, the Lp(a) assay is not optimized for baboon
Lp(a). Although we found a high repeatability (98.0%) and a strong
correlation with values derived from a baboon-specific assay
(r2=0.91), it is possible that the
assay values for baboon Lp(a) are biased. Despite the potential for
affecting the actual Lp(a) values reported herein, bias will not affect
the genetic results and their interpretation so long as there is a
strong correlation with true values. Second, several studies have
reported Lp(a) binding to or associated with
triglyceride-rich lipoproteins
(TRLs)31 32 33 and LDLs34 in humans. Given
that the Lp(a) assay measures apoB levels, a consequence of such
interactions (should they occur in the assay and be diet specific)
might be to give spuriously high Lp(a) readings for some diet samples.
Although we cannot rule out this possibility, we have not observed, in
density gradient analyses,13 17 21 apo(a) proteins
in density fractions more buoyant than Lp(a). Furthermore, baboons tend
to have relatively low plasma triglyceride concentrations
(
52 mg/dL on the basal diet and
37 mg/dL on the HFHC
diet35 and, consequently, low levels of TRLs.
The main thrust of our study was to determine whether dietary effects
on Lp(a) were mediated via genes as was suggested by our preliminary
study.14 Consistent with observations in studies
of humans,36 37 we found that
90% of the total
phenotypic variation in baboon Lp(a) was due to genes. However, we
found that the significant increase of Lp(a) levels in response to
increased level of dietary fat did not have a significant genetic
component. This result contrasts with that of Cantor et
al,30 who found that human Lp(a) levels significantly
decreased and that this decrease was highly heritable (maximum
h2
0.58). The authors also found no
significant evidence for linkage to a marker near the LPA
locus (P<0.07), suggesting that other, non-LPA
genes may mediate the response to dietary fat. In contrast to the lack
of genetic control of dietary responsiveness to fat in baboons, about
one third of the response to dietary cholesterol in the
high-fat environment was influenced by genes
(h2=0.347± 0.079,
P<0.0001). We are not aware of any previous study that has
assessed heritability of Lp(a) response to dietary
cholesterol.
After determining that basal Lp(a) and dietary cholesterol
responses were moderately to strongly influenced by genes, we tried to
identify the gene(s) by using linkage analysis. A number of
studies2 3 4 have reported that
90% of the phenotypic
variation in human Lp(a) is due to allelic variation at LPA,
the locus encoding the apo(a) protein. Similarly, we found that baboon
serum Lp(a) concentration in the 3 diet samples was strongly linked to
the LPA locus in this study as well (Table 2
). The
LOD score was 30.5 for basal Lp(a) levels, and LOD scores were even
higher for Lp(a) in the other diet samples [36.1 for
Lp(a)HFLC and 37.3 for
Lp(a)HFHC; data not shown]. We detected no
residual additive genetic variance in basal Lp(a) after accounting for
the LPA locus.
However, the Lp(a) cholesterol response variable was
not significantly linked to the LPA locus (Table 2
),
suggesting that an additional gene(s) influences Lp(a) response to
dietary cholesterol. Although most studies have identified
only the LPA locus as exerting a significant effect on Lp(a)
concentrations, a few studies do suggest the possibility of additional
genes. For example, in siblings concordant for LPA
genotype but discordant for heterozygous familial
hypercholesterolemia, Lp(a) concentrations were
significantly elevated in the familial
hypercholesterolemic siblings,38
clearly demonstrating a pleiotropic effect of the LDL receptor locus on
Lp(a) levels in persons with the rare disorder familial
hypercholesterolemia. In addition, it is likely
that LPA is not 1 of the gene(s) influencing dietary fat
response in humans.30
Because Lp(a) is a type of LDL, we hypothesized that genes influencing LDL concentrations might also affect Lp(a) concentrations. Although there was no genetic correlation of serum concentrations of LDL and Lp(a) on the basal diet, there was a highly significant genetic correlation for their responses to dietary cholesterol, indicating the same gene(s) influences both cholesterol response variables. This finding is likely to be relevant to humans, since several studies4 39 40 41 have reported significant phenotypic correlation of Lp(a) and LDLC concentrations, and the present data suggest that genes mediate at least a portion of the correlation. We hypothesize that a suite of genes influences the metabolism of ß-lipoproteins, thereby exerting a pleiotropic effect on Lp(a) concentrations as well. The finding of Lingenhel et al38 suggests that the LDL receptor gene may be 1 member of that suite, and further studies should reveal additional genes.
Previously, we found evidence for an unidentified major gene that influences most of the genetic variation in the LDLCRC trait in baboons.15 Because of the strong genetic correlation of LDLCRC and Lp(a)RC, we hypothesize that the major gene for LDLCRC is the principal non-LPA locus that also influences Lp(a) concentrations in baboons. Testing this hypothesis and identification of the non-LPA gene(s) that affects Lp(a) should be facilitated on completion of the baboon genome map.42
| Acknowledgments |
|---|
Received January 27, 1999; accepted April 19, 1999.
| References |
|---|
|
|
|---|
2. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest. 1992;90:5260.
3. DeMeester CA, Bu X, Gray RJ, Lusis AJ, Rotter JI. Genetic variation in lipoprotein (a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein (a) gene locus. Am J Hum Genet. 1995;56:287293.[Medline] [Order article via Infotrieve]
4. Rainwater DL. Lp(a) concentrations are related to plasma lipid concentrations. Atherosclerosis. 1996;127:1318.[Medline] [Order article via Infotrieve]
5. Perombelon YFN, Soutar AK, Knight BL. Variation in lipoprotein(a) concentration associated with different apolipoprotein(a) alleles. J Clin Invest. 1994;93:14811492.
6. Zock PL, Mensink RP. Dietary trans-fatty acids and serum lipoproteins in humans. Curr Opin Lipidol. 1996;7:3437.[Medline] [Order article via Infotrieve]
7. Lichtenstein AH. Trans fatty acids and blood lipid levels, Lp(a), parameters of cholesterol metabolism, and hemostatic factors. J Nutr Biochem. 1998;9:244248.
8. Albers JJ, Adolphson JL, Hazzard WR. Radioimmunoassay of human plasma Lp(a) lipoprotein. J Lipid Res. 1977;18:331338.[Abstract]
9.
Fless GM, Fischer-Dzoga K, Juhn DJ, Bates S, Scanu AM.
Structural and functional changes of rhesus serum low density
lipoproteins during cycles of diet-induced
hypercholesterolemia.
Arteriosclerosis. 1982;2:475486.
10. Neven L, Khalil A, Pfaffinger D, Fless GM, Jackson E, Scanu AM. Rhesus monkey model of familial hypercholesterolemia: relation between plasma Lp(a) levels, apo(a) isoforms, and LDL-receptor function. J Lipid Res. 1990;31:633643.[Abstract]
11. Brown SA, Morrisett J, Patsch JR, Reeves R, Gotto AM Jr, Patsch W. Influence of short term dietary cholesterol and fat on human plasma Lp(a) and LDL levels. J Lipid Res. 1991;32:12811289.[Abstract]
12. Sundell IB, Dahlén GH, Rånby M. Diet-induced changes in glucose and triglycerides are associated with changes in plasminogen activator inhibitor levels. Haemostasis. 1991;21:175180.[Medline] [Order article via Infotrieve]
13. Rainwater DL, Manis GS, VandeBerg JL. Hereditary and dietary effects on apolipoprotein(a) isoforms and Lp(a) in baboons. J Lipid Res. 1989;30:549558.[Abstract]
14. Rainwater DL. Genetic effects on dietary response of Lp(a) concentrations in baboons. Chem Phys Lipids. 1994;67/68:199205.
15.
Rainwater DL, Kammerer CM, Hixson JE, Carey KD, Rice
KS, Dyke B, VandeBerg JF, Slifer SH, Atwood LD, McGill HC Jr, VandeBerg
JL. Two major loci control variation in ß-lipoprotein
cholesterol and response to dietary fat and
cholesterol in baboons. Arterioscler Thromb Vasc
Biol. 1998;18:10611068.
16. Cheng M-L, Woodford SC, Hilburn JL, VandeBerg JL. A novel system for storage of sera frozen in small aliquots. J Biochem Biophys Methods. 1986;13:4751.[Medline] [Order article via Infotrieve]
17. Rainwater DL, Manis GS. Immunochemical characterization and quantitation of lipoprotein (a) in baboons: development of an assay depending on two antigenically distinct proteins. Atherosclerosis. 1988;73:2331.[Medline] [Order article via Infotrieve]
18. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470475.[Abstract]
19. Witte DL, Barrett DA II, Wycoff DA. Evaluation of an enzymatic procedure for determination of serum cholesterol with the Abbott ABA-100. Clin Chem. 1974;20:12821286.[Abstract]
20. Lipid Research Clinics Program. Manual of Laboratory Operations. Volume 1: Lipid and Lipoprotein Analysis. Washington DC: US Government Printing Office. Dept of Health, Education, and Welfare publication No. (NIH) 75628. 1974:5658.
21. Rainwater DL, Manis GS, Kushwaha RS. Characterization of an unusual lipoprotein similar to human lipoprotein a isolated from the baboon, Papio sp. Biochim Biophys Acta. 1986;877:7578.[Medline] [Order article via Infotrieve]
22. Lange K, Westlake J, Spence MA. Extensions to pedigree analysis, II: recurrence risk calculation under the polygenic threshold model. Hum Hered. 1976;26:337348.[Medline] [Order article via Infotrieve]
23. Hasstedt SJ. Variance components/major locus likelihood approximation for quantitative, polychotomous, and multivariate data. Genet Epidemiol. 1993;10:145158.[Medline] [Order article via Infotrieve]
24. Blangero J, Almasy L. Multipoint oligogenic linkage analysis of quantitative traits. Genet Epidemiol. 1997;14:959964.[Medline] [Order article via Infotrieve]
25. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet. 1998;62:11981211.[Medline] [Order article via Infotrieve]
26. Amos CI, Elston RC, Bonney GE, Keats BJB, Berenson GS. A multivariate method for detecting genetic linkage, with application to a pedigree with an adverse lipoprotein phenotype. Am J Hum Genet. 1990;47:247254.[Medline] [Order article via Infotrieve]
27. Rainwater DL, Lanford RE. Production of lipoprotein(a) by primary baboon hepatocytes. Biochim Biophys Acta. 1989;1003:3035.[Medline] [Order article via Infotrieve]
28.
Hixson JE, Britten ML, Manis GS, Rainwater DL.
Apolipoprotein(a) [apo(a)] glycoprotein isoforms result
from size differences in apo(a) mRNA in baboons. J Biol
Chem. 1989;264:60136016.
29. VandeBerg JL, Weitkamp L, Kammerer CM, Weill P, Aivaliotis MJ, Rainwater DL. Linkage of plasminogen (PLG) and apolipoprotein(a) (LPA) in baboons. Genomics. 1991;11:925930.[Medline] [Order article via Infotrieve]
30. Cantor RM, Blanche PJ, Lanning CD, Davis RC, Frernstom HS, Rawlings RS, Wen PZ, Holl LG, Orr JR, Lusis AJ, Rotter JI, Krauss RM. Genetic contributions to lipoprotein(a) levels on high and low saturated fat diets. Circulation. 1998;98(suppl I):I-738. Abstract.
31. Bersot TP, Innerarity TL, Pitas RE, Rall SC Jr, Weisgraber KH, Mahley RW. Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein (a) and that cause lipid accumulation in macrophages. J Clin Invest. 1986;77:622630.
32. Scanu AM, Pfaffinger D, Edelstein C. Post-prandial Lp(a): identification of a triglyceride-rich particle containing apo E. Chem Phys Lipids. 1994;67/68:193198.
33. Hoppichler F, Kraft HG, Sandholzer C, Lechleitner M, Patsch JR, Utermann G. Lipoprotein(a) is increased in triglyceride-rich lipoproteins in men with coronary heart disease, but does not change acutely following oral fat ingestion. Atherosclerosis. 1996;122:127134.[Medline] [Order article via Infotrieve]
34. Trieu VN, McConathy WJ. Lipoprotein(a) binding to other apolipoprotein B containing lipoproteins. Biochemistry. 1990;29:59195924.[Medline] [Order article via Infotrieve]
35. Kammerer CM, Mott GE, Carey KD, McGill HC Jr. Effects of selection for serum cholesterol concentrations on serum lipid concentrations and body weight in baboons. Am J Med Genet. 1984;19:333345.[Medline] [Order article via Infotrieve]
36. Utermann G, Haibach C, Trommsdorff M, Köchl S, Lingenhel A, Abe A, Kraft HG. Genetic architecture of the atherogenic lipoprotein(a). Ann N Y Acad Sci. 1995;748:301312.[Medline] [Order article via Infotrieve]
37. Berg K. Lp(a) lipoprotein and risk of atherosclerotic/thrombotic disease. Fibrinolysis Proteolysis. 1997;11(suppl 1):7175.
38. Lingenhel A, Kraft HG, Kotze M, Peeters AV, Kronenberg F, Kruse R, Utermann G. Concentrations of the atherogenic Lp(a) are elevated in FH. Eur J Hum Genet. 1998;6:5060.[Medline] [Order article via Infotrieve]
39.
Heinrich J, Sandkamp M, Kokott R, Schulte H, Assmann G.
Relationship of lipoprotein(a) to variables of coagulation and
fibrinolysis in a healthy population. Clin
Chem. 1991;37:19501954.
40. Ritter MM, Geiss HC, Richter WO, Schwandt P. Lipoprotein(a) concentrations and phenotypes in controls and patients with hypercholesterolemia or hypertriglyceridemia. Metabolism. 1994;43:572578.[Medline] [Order article via Infotrieve]
41. Bartens W, Rader DJ, Talley G, Brewer HB Jr. Lipoprotein (a) in patients with hyperlipidaemia. Eur J Clin Invest. 1995;25:647653.[Medline] [Order article via Infotrieve]
42. Rogers J, Hixson JE. Baboons as an animal model for genetic studies of common human disease. Am J Hum Genet. 1997;61:489493.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
D. L. Rainwater, L. A. Cox, J. Rogers, J. L. VandeBerg, and M. C. Mahaney Localization of multiple pleiotropic genes for lipoprotein metabolism in baboons J. Lipid Res., July 1, 2009; 50(7): 1420 - 1428. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M Ordovas Genetic influences on blood lipids and cardiovascular disease risk: tools for primary prevention Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1509S - 1517S. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |